Loxo shares skyrocketed nearly 65% on the news to $231.15.
The offer price of $235 per share in cash represents a premium of about 68% to Loxo's Friday close.
Last year, regulators approved Loxo's first commercial medicine called Vitrakvi, which had been shown to be effective against a wide variety of cancers.
DXC Technology (NYSE:DXC) and Luxoft Holding Inc (NYSE:LXFT) Monday announced that DXC would acquire Luxoft, which is a global-scale digital innovator, headquartered in Switzerland.
DXC shares added 4.68% to $60 each, while Luxoft Holding Inc surged 45% before the New York bell.
All issued and outstanding Luxoft Class A and Class B ordinary shares will receive $59.00 per share in cash, representing a total equity value of around $2 billion.
To electric car giant Tesla (NASDAQ:TSLA) and shares in the firm are up 1.83% to $323.50 in pre-market. On Friday, shares closed nearly 6% higher.
Reportedly, Tesla has now officially begun building its Gigafactory in Shanghai Monday, with CEO Musk breaking ground at the new plant.
Also in the news, CBS News said Susan Zirinsky, a senior executive producer, will become president from March this year as David Rhodes is stepping down.